immune system
• increased susceptibility to DSS-induced colitis on days 7 and 10 post-DSS treatment
|
• increased T-independent antibody response to 4-hydroxy-3-nitrophenylacetyl-Ficoll (NP-Ficoll)
|
• increased T-independent antibody response to 4-hydroxy-3-nitrophenylacetyl-Ficoll (NP-Ficoll)
|
digestive/alimentary system
• increased susceptibility to DSS-induced colitis on days 7 and 10 post-DSS treatment
|
hematopoietic system
• increased T-independent antibody response to 4-hydroxy-3-nitrophenylacetyl-Ficoll (NP-Ficoll)
|